Action BDSX BIODESIX, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Biodesix, Inc.

Actions

BDSX

US09075X1081

Temps réel estimé Cboe BZX
Autres places de cotation
 17:16:24 10/05/2024 		Varia. 5j. Varia. 1 janv.
1,5 USD -3,23 % Graphique intraday de Biodesix, Inc. +6,43 % -19,02 %
08/05 Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024
08/05 Biodesix, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Biodesix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Earnings Flash (BDSX) BIODESIX Reports Q1 Revenue $14.8M, vs. Street Est of $14.2M
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
Biodesix, Inc. announced that it has received $34.999422 million in funding
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
Top Midday Decliners
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
Biodesix, Inc. announced that it expects to receive $34.999422 million in funding
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
Biodesix Announces New Master Collaborative Research Agreement with Memorial Sloan Kettering Cancer Center
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
Biodesix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Biodesix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Biodesix, Inc. Provides Revenue Guidance for the Year 2024
Earnings Flash (BDSX) BIODESIX Posts Q4 Revenue $14.7M
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BDSX
  4. Actualités Biodesix, Inc.
  5. Autres langues